Clinical Trials Directory

Trials / Terminated

TerminatedNCT00118573

Comparison of Surveillance Versus Aortic Endografting for Small Aneurysm Repair

Randomized Clinical Trial Comparing Surveillance and Selective Surgical Treatment for Abdominal Aortic Aneurysms Less Than 5.5 cm in Diameter Versus Early Endovascular Treatment

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
360 (actual)
Sponsor
University Of Perugia · Academic / Other
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Objective of the present study is to compare endovascular repair versus surveillance and, eventually delay treatment in patients with small abdominal aortic aneurysms (AAA), with respect to patient survival, AAA rupture and AAA related death risks.

Detailed description

The study will include patients with small AAA (diameter 4.1 to 5.4 cm defined by Computed Tomographic scan) suitable for endovascular repair (EVAR). Randomization is designed with equal probability of assignment to each of the two groups (ie, immediate endovascular repair or surveillance group) by means of a computer-generated -random-number list . After eligibility is verified, assignment will be made using a computer database held at the Coordinating Centre. In the immediate repair group, endovascular repair with introduction of an aortic endograft (Cook Zenith) will be performed within six weeks from randomization. In the surveillance group, patients are followed without repair until the aneurysm reaches 5.5 cm in diameter, or enlarges at least 1.0 cm in one year, or until patient develops symptoms that are attributed to the aneurysm by the attending investigator. When one of these criteria is met, endovascular repair (if the patient remains a candidate for EVAR), or open repair will be carried out.

Conditions

Interventions

TypeNameDescription
PROCEDUREEVAR (Endovascular repair of Abdominal Aortic aneurysm)AAA repair with endografting
PROCEDURESurveillanceSurveillance of AAA without any repair until AAA will reach 5.5cm, become tender or rapidly grow

Timeline

Start date
2004-09-01
Primary completion
2010-05-01
Completion
2017-09-01
First posted
2005-07-11
Last updated
2015-12-10

Locations

20 sites across 9 countries: Czechia, France, Germany, Israel, Italy, Netherlands, Poland, Spain, United Kingdom

Source: ClinicalTrials.gov record NCT00118573. Inclusion in this directory is not an endorsement.